Prevalence of KRAS p.(G12C) in stage IV NSCLC patients in the Netherlands; a nation-wide retrospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence of KRAS p.(G12C) in stage IV NSCLC patients in the Netherlands; a nation-wide retrospective cohort study

Published:2022-05 Issue: Volume:167 Page:1-7
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Garcia Betzabel N. Cajiao,van Kempen Léon C.,Kuijpers Chantal C.H.J.,Schuuring Ed,Willems Stefan M.,van der Wekken Anthonie J.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference54 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur. J. Cancer,2013

2. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

3. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing;Imielinski;Cell,2012

4. Comprehensive molecular profiling of lung adenocarcinoma;Collisson;Nat,2014

5. The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma;Biernacka;Cancer Genet,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinoma;Pathology;2024-10

2. Returning from the afterlife? Sotorasib treatment for advanced KRAS mutant lung cancer: A case report;World Journal of Clinical Cases;2024-09-06

3. Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands;European Journal of Cancer;2024-07

4. Comparison Between Sotorasib with Docetaxel for the Treatment of Chinese Patients with Previously Treated NSCLC with KRASG12C Mutation: A Cost-Effectiveness Analysis to Inform Drug Pricing;Advances in Therapy;2024-06-18

5. Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort;ESMO Open;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3